The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta‐analysis and systematic review

BACKGROUND AND AIM: Metabolic syndrome (MetS) increases the risk of colorectal cancer (CRC), and the impact of MetS on CRC prognosis remains controversial after the diagnosis of CRC has been established. This study aimed to explore the impact of the individual components and synergies of MetS on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Bo, Qian, Jia‐Ming, Li, Jing‐Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100176/
https://www.ncbi.nlm.nih.gov/pubmed/36287138
http://dx.doi.org/10.1111/jgh.16042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100176/
https://www.ncbi.nlm.nih.gov/pubmed/36287138
http://dx.doi.org/10.1111/jgh.16042

Ejemplares similares